Home > BIGG > Search result

    Results: 2

    The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs: policy guidance

    World Health Organization.
    This document provides a summary of the evidence and recommendations for the use of SL-LPA for the detection of mutations associated with resistance to fluoroquinolones and SLID in patients with RR-TB and/or MDR-TB. The objectives of this policy guidance are to assess and compare the diagnostic accuracy ...
    Tuberculosis, Multidrug-Resistant/diagnosis, Antibiotics, Antitubercular/pharmacology, Molecular Probe Techniques, Microbial Sensitivity Tests, Fluoroquinolones/therapeutic use, Drug Resistance, Bacterial/genetics, Genotype, Mutation, Tuberculosis, Multidrug-Resistant/genetics, Mycobacterium tuberculosis/drug effects, Mycobacterium tuberculosis/genetics
    Fulltext

    Noncommercial culture and drug-susceptibility testing methods for screening patients at risk for multidrug-resistant tuberculosis: policy statement

    World Health Organization.
    Commercial liquid culture systems and molecular line-probe assays have been endorsed by the World Health Organization (WHO) as gold standards for rapid detection of multidrug-resistant (MDR) tuberculosis (TB); however, because of technical complexity, cost and the requirement for sophisticated laboratory...
    Tuberculosis, Multidrug-Resistant, Antitubercular Agents, Microbial Sensitivity Tests, Mycobacterium tuberculosis/isolation & purification
    Fulltext